Results
|
|
101.
|
|
|
|
102.
|
|
|
|
103.
|
|
|
|
104.
|
|
|
|
105.
|
|
|
|
106.
|
|
|
|
107.
|
|
|
|
108.
|
|
|
|
109.
|
|
|
|
110.
|
|
|
|
111.
|
|
|
|
112.
|
|
|
|
113.
|
|
|
|
114.
|
|
|
|
115.
|
|
|
|
116.
|
|
|
|
117.
|
Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study. MedStar authors:
Year: 2022
Citation: - Journal of Clinical Oncology. 40(5):438-448, 2022 02 10.
Department: - Associate Dean for Research Development
Medline publication type:
All authors: - Barrios C, Bonnefoi H, Boulet T, De Laurentiis M, Ellis PA, Fehrenbacher L, Gianni L, Gralow J, Harbeck N, Huang CS, Im SA, Im YH, Ito Y, Krop IE, Liu H, Macharia H, Nowecki Z, Shah J, Song C, Swain SM, Toi M, Trask P, Winer EP
|
|
|
118.
|
|
|
|
119.
|
Incidence and severity of anaphylaxis and hypersensitivity in trials of intravenous pertuzumab plus trastuzumab or the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection for HER2-positive breast cancer. MedStar authors:
Year: 2022
Citation: - European Journal of Cancer. 178:70-81, 2022 Oct 07.
Medline publication type:
All authors: - Aguila C, Dang CT, Gianni L, Heeson S, Kuemmel S, Liu H, Loibl S, Macharia H, O'Shaughnessy J, Restuccia E, Schneeweiss A, Swain SM, Tan AR, Yang K
|
|
|
120.
|
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology). MedStar authors:
Year: 2022
Citation: - Breast Cancer Research & Treatment. 193(3):565, 2022 Jun.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Baez-Diaz L, Bandos H, Brufsky AM, Carolla RL, Fehrenbacher L, Geyer CE Jr, Hamm JT, Jacobs SA, Julian TB, Mamounas EP, Paterson AHG, Polikoff J, Provencher L, Rastogi P, Robidoux A, Swain SM, Ward PJ, Wolmark N
|
|
|
121.
|
Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and management. [Review] MedStar authors:
Year: 2022
Citation: - Cancer Treatment Reviews. 106:102378, 2022 May.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Andre F, Bartholmai BJ, Conte P, Kato T, Lancaster LH, Li BT, Naidoo J, Nicholson AG, Nishino M, Powell CA, Schumacher-Wulf E, Shitara K, Swain SM, Tsurutani J
|
|
|
122.
|
Pazopanib for the treatment of breast cancer. [Review] MedStar authors:
Year: 2012
Citation: - Expert Opinion on Investigational Drugs. 21(2):217-25, 2012 Feb.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Review
All authors: - Amiri-Kordestani L, Swain SM, Tan AR
|
|
|
123.
|
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA). MedStar authors:
Year: 2013
Citation: - Breast Cancer Research & Treatment. 142(1):89-99, 2013 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Amadori D, Baselga J, Clark E, Knott A, Miles D, Ross G, Semiglazov V, Sunpaweravong P, Swain SM
|
|
|
124.
|
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. MedStar authors:
Year: 2013
Citation: - Annals of Oncology. 24(10):2630-5, 2013 Oct.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Clark E, Cortes J, Im SA, Im YH, Knott A, Pivot X, Ross G, Swain SM
|
|
|
125.
|
Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer. MedStar authors:
Year: 2014
Citation: - Cancer. 120(17):2657-64, 2014 Sep 1.
Institution: - Washington Cancer Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Observational Study
- Research Support, Non-U.S. Gov't
All authors: - Bloom KJ, Brammer MG, Burris H, Chau M, Gralow JR, Kaufman PA, Lalla D, Mayer M, Pegram M, Rugo HS, Swain SM, Vogel CL, Yardley DA, Yoo B
|
|
|
126.
|
Building bridges to conquer cancer. MedStar authors:
Year: 2013
Citation: - Journal of Clinical Oncology. 31(30):3731-6, 2013 Oct 20.
Institution: - Washington Cancer Institute
Medline publication type:
|
|
|
127.
|
Locoregional recurrence (LRR) after neoadjuvant chemotherapy (NAC): Pooled-analysis results from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC). MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(26_suppl):61, 2014 Sep 10
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Bogaerts J, Bonnefoi HR, Cameron DA, Cortazar P, Costantino JP, Eidtmann H, Gerber B, Geyer CE, Gianni L, Loibl S, Mehta K, Rastogi P, Sridhara R, Swain SM, Untch M, Valagussa P, Von Minckwitz G, Wolmark N, Zhang L
|
|
|
128.
|
|
|
|
129.
|
|
|
|
130.
|
|
|
|
131.
|
|
|
|
132.
|
|
|
|
133.
|
|
|
|
134.
|
|
|
|
135.
|
|
|
|
136.
|
|
|
|
137.
|
|
|
|
138.
|
|
|
|
139.
|
|
|
|
140.
|
|
|
|
141.
|
|
|
|
142.
|
|
|
|
143.
|
|
|
|
144.
|
|
|
|
145.
|
|
|
|
146.
|
|
|
|
147.
|
|
|
|
148.
|
|
|
|
149.
|
|
|
|
150.
|
|
|
|
151.
|
|
|
|
152.
|
|
|
|
153.
|
|
|
|
154.
|
|
|
|
155.
|
|
|
|
156.
|
|
|
|
157.
|
|
|
|
158.
|
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41. MedStar authors:
Year: 2023
Citation: - Breast Cancer Research & Treatment. 2023 Mar 22
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Rastogi P, Tang G, Hassan S, Geyer CE Jr, Azar CA, Magrinat GC, Suga JM, Bear HD, Baez-Diaz L, Sarwar S, Boileau JF, Brufsky AM, Shibata HR, Bandos H, Paik S, Yothers G, Swain SM, Mamounas EP, Wolmark N
|
|
|
159.
|
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up . MedStar authors:
Year: 2023
Citation: - Annals of Oncology. 2023 Dec 08
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Loibl S, Andre F, Bachelot T, Barrios CH, Bergh J, Burstein HJ, Cardoso LMJ, Carey LA, Dawood S, Del Mastro L, Denkert C, Fallenberg EM, Francis PA, Gamal-Eldin H, Gelmon K, Geyer CE, Gnant M, Guarneri V, Gupta S, Kim SB, Krug D, Martin M, Meattini I, Morrow M, Janni W, Paluch-Shimon S, Partridge A, Poortmans P, Pusztai L, Regan MM, Sparano J, Spanic T, Swain S, Tjulandin S, Toi M, Trapani D, Tutt A, Xu B, Curigliano G, Harbeck N
|
|
|
160.
|
Accessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluation. MedStar authors:
Year: 2024
Citation: - Journal of Clinical Epidemiology. 167:111263, 2024 Mar.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Hopkins AM, Modi ND, Rockhold FW, Hoffmann T, Menz BD, Veroniki AA, McKinnon RA, Rowland A, Swain SM, Ross JS, Sorich MJ
|
|
|
161.
|
|
|
|
162.
|
Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer. MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Year: 2020
Citation: - Frontiers in Oncology. 10:1475, 2020.
Institution: - Washington Cancer Institute
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Elliott A, Gatalica Z, Heeke AL, Isaacs C, Khoury K, Korn WM, Lynce F, Pohlmann PR, Schwartzberg LS, Simon M, Swain SM, Tan AR, Xiu J
|
|
|
163.
|
Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx R Digital Spatial Profiler. MedStar authors:
- Schlam, Ilana
- Swain, Sandra M
Year: 2021
Citation: - Cancers. 13(17), 2021 Sep 04.
Institution: - MedStar Washington Hospital Center
Department:
- Associate Dean for Research Development
- Hematology and Oncology
- MedStar Health
Medline publication type:
All authors: - Bergholtz H, Carter JM, Cesano A, Cheang MCU, Church SE, Divakar P, Fuhrman CA, Goel S, Gong J, Guerriero JL, Hoang ML, Hwang ES, Kuasne H, Lee J, Liang Y, Mittendorf EA, On Behalf Of The GeoMx Breast Cancer Consortium, Perez J, Prat A, Pusztai L, Reeves JW, Riazalhosseini Y, Richer JK, Sahin O, Sato H, Schlam I, Sorlie T, Stover DG, Swain SM, Swarbrick A, Thompson EA, Tolaney SM, Warren SE
|
|
|
164.
|
|
|
|
165.
|
Pertuzumab for the treatment of breast cancer. [Review] MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Year: 2014
Citation: - Cancer Investigation. 32(8):430-8, 2014 Oct.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
- Review
|
|
|
166.
|
|
|
|
167.
|
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway. MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Year: 2020
Citation: - Breast Cancer Research & Treatment. 184(2):265-275, 2020 Nov.
Institution: - Washington Cancer Institute
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Elliott A, Heeke AL, Isaacs C, Korn WM, Lynce F, Pohlmann PR, Schwartzberg LS, Swain SM, Tan AR, Vidal G, Xiu J
|
|
|
168.
|
Phase I/II study of trastuzumab, pertuzumab, palbociclib and fulvestrant in patients with HER2-positive and hormone receptor positive metastatic breast cancer MedStar authors:
- Herbolsheimer, Pia
- Swain, Sandra M
Year: 2016
All authors: - Herbolsheimer P, Riggins R, Pohlmann P, ElChaarani B, Isaacs C, Cai L, Swain SM
|
|
|
169.
|
Avastin withdrawal symptoms. MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Citation: - Expert Opinion on Pharmacotherapy. 13(3):293-8, 2012 Feb.
Institution: - Washington Cancer Institute
Medline publication type:
- Editorial
- Research Support, Non-U.S. Gov't
|
|
|
170.
|
|
|
|
171.
|
|
|
|
172.
|
Pertuzumab: increasing the options. MedStar authors:
- Nunes, Raquel
- Swain, Sandra M
Citation: - Oncology (Williston Park). 28(3):199, 204, 210, 2014 Mar.
Institution: - Washington Cancer Institute
Medline publication type:
- Comment
- Journal Article
- Research Support, Non-U.S. Gov't
|
|
|
173.
|
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2. MedStar authors:
- Swain, Sandra M
- Zapas, John L
Year: 2017
Citation: - Journal of Clinical Oncology. 35(35):3942-3948, 2017 Dec 10
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Atkins JN, Biggs DD, Brufsky AM, Cecchini RS, Fehrenbacher L, Flynn PJ, Ganz PA, Geyer CE Jr, Gross HM, Jeong JH, Mamounas EP, Polikoff J, Rastogi P, Romond EH, Seay TE, Swain SM, Wade JL 3rd, Wahl TA, Wolmark N, Zapas JL
|
|
|
174.
|
DPYD Testing: Time to Put Patient Safety First. MedStar authors:
- Smith, D Max
- Swain, Sandra M
Year: 2023
Citation: - Journal of Clinical Oncology. :JCO2202364, 2023 Feb 23
Department:
- Associate Dean for Research Development
- MedStar Health
- Pharmacogenomics
Medline publication type:
All authors: - Baker SD, Bates SE, Brooks GA, Dahut WL, Diasio RB, El-Deiry WS, Evans WE, Figg WD, Hertz DL, Hicks JK, Kamath S, Kasi PM, Knepper TC, McLeod HL, O'Donnell PH, Relling MV, Rudek MA, Sissung TM, Smith DM, Sparreboom A, Swain SM, Walko CM
|
|
|
175.
|
Best-worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy. MedStar authors:
- Smith, D Max
- Swain, Sandra M
Year: 2022
Citation: - Implementation Science Communications. 3(1):52, 2022 May 14.
Department:
- Associate Dean for Research Development
- MedStar Health
- Pharmacogenomics
Medline publication type:
All authors: - Aquilante CL, Bates J, Beitelshees AL, Bishop JR, Blake KV, Cavallari LH, Cipriani A, Duong BQ, Elchynski AL, Empey PE, Formea CM, Hicks JK, Limdi NA, Mroz P, Oslin D, Pasternak AL, Petry N, Ramsey LB, Rowe E, Salloum RG, Schlichte A, Skaar TC, Smith DM, Swain SM, Tuteja S, Van Driest SL, Ward KM, Wiisanen K
|
|
|
176.
|
Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30. MedStar authors:
- McCarron, Edward C
- Swain, Sandra M
Year: 2018
Citation: - Journal of the National Cancer Institute. 110(2), 2018 Feb 01
Institution:
- MedStar Franklin Square Medical Center
- Washington Cancer Institute
Medline publication type:
All authors: - Bandos H, Brufsky AM, Fehrenbacher L, Ganz PA, Julian TB, Margolese RG, McCarron EC, Melnikow J, Rivera DR, Sturtz K, Swain SM, Wade JL 3rd
|
|
|
177.
|
DPYD Testing: Time to Put Patient Safety First. MedStar authors:
- Smith, D Max
- Swain, Sandra M
Year: 2023
Citation: - Journal of Clinical Oncology. 41(15):2701-2705, 2023 May 20.
Department:
- Associate Dean for Research Development
- MedStar Health
- Pharmacogenomics
Medline publication type:
All authors: - Baker SD, Bates SE, Brooks GA, Dahut WL, Diasio RB, El-Deiry WS, Evans WE, Figg WD, Hertz DL, Hicks JK, Kamath S, Kasi PM, Knepper TC, McLeod HL, O'Donnell PH, Relling MV, Rudek MA, Sissung TM, Smith DM, Sparreboom A, Swain SM, Walko CM
|
|
|
178.
|
Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy. MedStar authors:
- Smith, D Max
- Swain, Sandra M
Year: 2022
Citation: - Clinical and translational science. 15(2):371-383, 2022 02.
Department:
- Associate Dean for Research Development
- MedStar Health
- Pharmacogenomics
Medline publication type:
All authors: - Aquilante CL, Bates J, Beitelshees AL, Bishop JR, Blake KV, Cavallari LH, Cipriani A, Duong BQ, Elchynski AL, Empey PE, Formea CM, Hicks JK, IGNITE Pharmacogenetics Working Group, Limdi NA, Mroz P, Oslin D, Pasternak AL, Petry N, Ramsey LB, Rowe E, Salloum RG, Schlichte A, Skaar TC, Smith DM, Swain SM, Tuteja S, Van Driest SL, Ward KM, Wiisanen K
|
|
|
179.
|
Ten-year Update: NRG Oncology/NSABP B-42 Randomized Trial: Extended Letrozole Therapy in Early-stage Breast Cancer. MedStar authors:
- McCarron, Edward C
- Swain, Sandra M
Year: 2023
Citation: - Journal of the National Cancer Institute. 2023 May 15
Institution:
- Associate Dean for Research Development
- MedStar Franklin Square Medical Center
- MedStar Health
Medline publication type:
All authors: - Bandos H, Brufsky AM, Chia SK, Dakhil SR, Fehrenbacher L, Geyer CE, Jeong JH, Lembersky BC, Mamounas EP, McCarron EC, Rastogi P, Soori GS, Swain SM, Wade JL, Walshe JM, Wolmark N
|
|
|
180.
|
|
|
|
181.
|
|
|
|
182.
|
|
|
|
183.
|
Focus on You: Cancer clinical trials perspectives. MedStar authors:
- Newman, Antoinette F
- Robinson, Brandi N
- Swain, Sandra M
Year: 2016
Citation: - Contemporary Clinical Trials Communications. 4:170-178, 2016 Dec 15
Institution:
- MedStar Health Research Institute
- Washington Cancer Institute
Medline publication type:
All authors: - Newman AF, Robinson BN, Swain SM, Wallington SF
|
|
|
184.
|
SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Lynce, Filipa
- Swain, Sandra M
Year: 2017
Citation: - Oncologist. 22(5):518-525, 2017 May
Institution:
- MedStar Heart & Vascular Institute
- Washington Cancer Institute
Medline publication type:
All authors: - Asch FM, Barac A, Dang C, Isaacs C, Lynce F, Smith KL, Swain SM, Tan MT
|
|
|
185.
|
Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectives. MedStar authors:
- Bhatt, Meghna
- Kazi, Sadaf
- Smith, D Max
- Swain, Sandra M
Year: 2023
Citation: - Pharmacogenomics. 24(16):859-870, 2023 Nov.
Institution:
- MedStar Institute for Innovation
- MedStar Washington Hospital Center
Department:
- Associate Dean for Research Development
- MedStar Health
- National Center for Human Factors in Healthcare
- Pharmacogenomics
- Pharmacy Residency
Medline publication type:
All authors: - Bhatt M, Peshkin BN, Kazi S, Schwartz MD, Ashai N, Swain SM, Smith DM
|
|
|
186.
|
A pilot study of a culturally targeted video intervention to increase participation of African American patients in cancer clinical trials. MedStar authors:
- Banda, Deliya R
- Libin, Alexander V
- Swain, Sandra M
- Wang, Hong
Year: 2012
Citation: - Oncologist. 17(5):708-14, 2012.
Institution:
- MedStar Health Research Institute
- MedStar National Rehabilitation Network
- Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Banda DR, Libin AV, Swain SM, Wang H
|
|
|
187.
|
Nivolumab or capecitabine or combination therapy as adjuvant therapy for triple negative breast cancer (TNBC) with residual disease following neoadjuvant chemotherapy: the OXEL study. MedStar authors:
- Dilawari, Asma
- Gallagher, Christopher
- Khoury, Katia
- Lynce, Filipa
- Swain, Sandra M
Year: 2018
Department: - MedStar Georgetown University Hospital Residents
All authors: - Khoury K, Isaacs C, Gatti-Mays M, Donahue R, Schlom J, Wang H, Gallagher C, Graham D, Warren R, Dilawari A, Swain S, Pohlmann P, Lynce F.
|
|
|
188.
|
Nivolumab or capecitabine or combination therapy as adjuvant therapy for triple negative breast cancer (TNBC) with residual disease following neoadjuvant chemotherapy: the OXEL study. MedStar authors:
- Dilawari, Asma
- Gallagher, Christopher
- Khoury, Katia
- Lynce, Filipa
- Swain, Sandra M
Year: 2019
Department: - MedStar Georgetown University Hospital Residents
All authors: - Khoury K, Isaacs C, Gatti-Mays M, Donahue R, Schlom J, Wang H, Gallagher C, Graham D, Warren R, Dilawari A, Swain S, Pohlmann P, Lynce F.
|
|
|
189.
|
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane. MedStar authors:
- Kurian, Shweta
- Mohebtash, Mahsa
- Ottaviano, Yvonne
- Rao, Suman
- Swain, Sandra M
Year: 2022
Citation: - Breast Cancer Research & Treatment. 196(3):571-581, 2022 Dec.
Institution: - MedStar Franklin Square Medical Center
Department:
- Associate Dean for Research Development
- Hematology/Oncology
- MedStar Health
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Randomized Controlled Trial
All authors: - Dilawari A, Graham D, Isaacs C, Kurian S, Lynce F, Mainor C, McNamara D, Mohebtash M, Ottaviano Y, Pohlmann PR, Rao S, Swain SM, Swanson N, Tan M, Warren R, Wu T
|
|
|
190.
|
Take care of your neighborhood. MedStar authors:
- Huerta, Elmer E
- Swain, Sandra M
- Weeks-Coulthurst, Patricia
- Williams, Courtney
Year: 2018
Citation: - Breast Cancer Research & Treatment. 167(1):225-234, 2018 01.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Huerta EE, Swain SM, Weeks-Coulthurst P, Williams C
|
|
|
191.
|
Clinical pharmacogenetics pilot at MedStar Health: A surgical perspective. MedStar authors:
- Levin, Bonnie
- McAlduff, Joel
- Shapiro, Richard
- Smith, DM
- Swain, Sandra M
Year: 2019
All authors: - Smith DM, Peshkin BN, Springfield TB, Kmiecik SO, Shapiro R, McAlduff J, Levin B, Swain SM.
|
|
|
192.
|
Evaluation of a longitudinal pharmacogenomics education on pharmacist knowledge in a multicampus healthcare system. MedStar authors:
- Hui, Adrian C
- Lee, Andrew J
- Smith, D Max
- Swain, Sandra M
- Walker, Alexander
Year: 2022
Citation: - Pharmacogenomics. 23(3):173-182, 2022 02.
Institution:
- MedStar Institute for Innovation
- MedStar Union Memorial Hospital
Department:
- Associate Dean for Research Development
- MedStar Health
- Pharmacogenomics
- Pharmacy
Medline publication type:
All authors: - Hui AC, Lee AJ, Peshkin BN, Smith DM, Swain SM, Walker AD
|
|
|
193.
|
Genomic profiling of breast cancer in African-American women using MammaPrint. MedStar authors:
- Boisvert, Marc E
- Herbolsheimer, Pia M
- Mete, Mihriye
- Nunes, Raquel
- Swain, Sandra M
- Wray, Lynette
Year: 2016
Citation: - Breast Cancer Research & Treatment. 159(3):481-8, 2016 Oct
Institution:
- MedStar Health Research Institute
- Washington Cancer Institute
Medline publication type:
All authors: - Bijelic L, Boisvert ME, Herbolsheimer P, Mete M, Nunes RA, Smith KL, Swain SM, Wray L
|
|
|
194.
|
Genomic profiling of breast cancer in African American women - final results MedStar authors:
- Boisvert, Marc C
- Godwin, Thomas A
- Herbolsheimer, Pia
- Mete, Mihriye
- Nunes, Maria Raquel
- Swain, Sandra M
- Wray, Lynnette
Year: 2016
All authors: - Nunes RA, Wray L, Mete M, Godwin TA, Herbolsheimer P, Smith KL, Bijelic L, Boisvert ME, Swain SM
|
|
|
195.
|
Clinical pharmacogenetics at MedStar Health: A pilot. MedStar authors:
- Eldadah, Zayd A
- Levin, Bonnie
- Lundergan, Conor F
- McAlduff, Joel
- Shapiro, Richard
- Smith, DM
- Swain, Sandra M
Year: 2019
All authors: - Smith DM, Peshkin BN, Springfield TB, Kmiecik SO, Shapiro R, Eldadah Z, Lundergan CF, McAlduff J, Levin B, Swain SM.
|
|
|
196.
|
Cardiac function in BRCA1/2 mutation carriers with a history of breast cancer treated with anthracyclines MedStar authors:
- Barac, Ana
- Herbolsheimer, Pia M
- Isaacs, C
- Lynce, Filipa
- Mete, Mihriye
- Nunes, Raquel
- Swain, Sandra M
Year: 2015
Department: - MedStar Heart and Vascular Institute
All authors: - Barac A, Lynce F, Mete M, Herbolsheimer P, Nunes R, Swain S, Warren R, Isaacs C
|
|
|
197.
|
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Gallagher, Christopher
- Hofmeyer, Mark
- Lynce, Filipa
- Srichai, Monvadi B
- Swain, Sandra M
Year: 2021
Citation: - Breast Cancer Research & Treatment. 2021 Jan 05
Institution:
- MedStar Heart & Vascular Institute
- Washington Cancer Institute
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Asch F, Barac A, Dang C, Gallagher C, Geng X, Herbolsheimer P, Hofmeyer M, Isaacs C, Khoury K, Lynce F, Nunes R, Pohlmann PR, Smith KL, Srichai MB, Swain SM, Tan M, Warren R, Yu AF
|
|
|
198.
|
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Cunningham, A
- Gallagher, Christopher
- Hofmeyer, Mark
- Srichai, M B
- Swain, Sandra M
Year: 2019
Citation: - Breast Cancer Research & Treatment. 175(3):595-603, 2019 Jun.
Institution:
- MedStar Health
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
- Washington Cancer Institute
Department: - Associate Dean for Research Development
Medline publication type:
All authors: - Asch FM, Barac A, Cunningham A, Dang C, Gallagher C, Geng X, Herbolsheimer P, Hofmeyer M, Isaacs C, Lynce F, Nunes R, Pohlmann PR, Shajahan-Haq A, Smith KL, Srichai MB, Swain SM, Tan MT, Timothee P, Warren R, Yu AF
|
|
|
199.
|
Phase I trial of dasatinib and ixabepilone in patients with solid tumors. MedStar authors:
- Herbolsheimer, Pia M
- Jelinek, James S
- Kapoor, R
- Perry, David J
- Smith, Karen L
- Swain, Sandra M
- Verma, Nitin
- Veytsman, Irina
Citation: - Investigational New Drugs. 31(1):92-8, 2013 Feb.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase I
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Herbolsheimer P, Jelinek J, Kapoor R, Perry D, Smith KL, Swain SM, Verma N, Veytsman I
|
|
|
200.
|
Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing. MedStar authors:
- Brandt, Nicole
- Brown, Ryan P
- Levin, Bonnie
- Smith, D Max
- Swain, Sandra M
- Walsh, Richard J
- Welsh, James C
Year: 2020
Citation: - Pharmacogenomics. 21(15):1085-1094, 2020 10.
Department:
- Assistant Vice President
- Associate Dean for Research Development
- MedStar Center for Successful Aging
- MedStar Health
- Pharmacogenomics
- Vice President
Medline publication type:
All authors: - Brandt N, Brown RP, Levin B, Namvar T, Peshkin BN, Smith DM, Springfield TB, Swain SM, Walsh RJ, Welsh JC
|
